Commission Regulation (EU) 2026/189 of 28 January 2026 amending Regulation (EC) No 1333/2008 of the European Parliament and the Council and Commission Regulation (EU) No 231/2012 as regards the use of shellac (E 904) in food for special medical purposes in tablet and coated tablet forms
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD)
Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XII Foodstuffs
Joint committee decision (JCD)
121/2026
In force in the EEA
Yes
Legal Documents
Commission Regulation (EU) 2026/189 of 28 January 2026 amending Regulation (EC) No 1333/2008 of the European Parliament and the Council and Commission Regulation (EU) No 231/2012 as regards the use of shellac (E 904) in food for special medical purposes in tablet and coated tablet forms
Reglugerð framkvæmdastjórnarinnar (ESB) 2026/189 frá 28. janúar 2026 um breytingu á reglugerð Evrópuþingsins og ráðsins (EB) nr. 1333/2008 og reglugerð framkvæmdastjórnarinnar (ESB) nr. 231/2012 að því er varðar notkun á skellakki (E 904) í matvæli sem eru notuð í sérstökum læknisfræðilegum tilgangi í formi taflna og húðaðra taflna
Verordnung (EU) 2026/189 der Kommission vom 28. Januar 2026 zur Änderung der Verordnung (EG) Nr. 1333/2008 des Europäischen Parlaments und des Rates und der Verordnung (EU) Nr. 231/2012 der Kommission in Bezug auf die Verwendung von Schellack (E 904) in Lebensmitteln für besondere medizinische Zwecke in Form von Komprimaten und überzogenen Tabletten
History
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.